Caption Management, LLC Uro Gen Pharma Ltd. Transaction History
Caption Management, LLC
- $6.26 Billion
- Q1 2024
A detailed history of Caption Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Caption Management, LLC holds 2,400 shares of URGN stock, worth $37,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,400Holding current value
$37,632% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding URGN
# of Institutions
113Shares Held
23.6MCall Options Held
46.9KPut Options Held
44.3K-
Rtw Investments, LP New York, NY3.26MShares$51.1 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.62MShares$41.1 Million9.62% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$36.1 Million0.26% of portfolio
-
Black Rock Inc. New York, NY1.72MShares$26.9 Million0.0% of portfolio
-
Cowen And Company, LLC1.63MShares$25.5 Million0.82% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $357M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...